National Health Investors (NYSE:NHI – Get Free Report) was upgraded by stock analysts at Truist Financial from a “hold” rating to a “buy” rating in a research report issued on Wednesday,Briefing.com Automated Import reports. The firm presently has a $77.00 price target on the real estate investment trust’s stock. Truist Financial’s price objective would indicate a potential upside of 10.74% from the company’s previous close.
Separately, Wedbush reissued an “outperform” rating and set a $88.00 price target on shares of National Health Investors in a research report on Monday, March 17th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $85.75.
National Health Investors Stock Performance
NHI opened at $69.53 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 16.55 and a quick ratio of 16.55. The business has a fifty day simple moving average of $73.12 and a 200 day simple moving average of $71.60. National Health Investors has a 1 year low of $65.13 and a 1 year high of $86.13. The company has a market capitalization of $3.25 billion, a PE ratio of 22.07, a price-to-earnings-growth ratio of 4.22 and a beta of 0.73.
National Health Investors (NYSE:NHI – Get Free Report) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The business had revenue of $68.87 million for the quarter, compared to the consensus estimate of $85.13 million. National Health Investors’s revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.10 earnings per share. Research analysts expect that National Health Investors will post 4.41 EPS for the current year.
Institutional Investors Weigh In On National Health Investors
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC lifted its position in shares of National Health Investors by 49.8% during the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock worth $33,000 after buying an additional 147 shares during the last quarter. Loomis Sayles & Co. L P raised its stake in National Health Investors by 42.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 639 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 189 shares in the last quarter. GF Fund Management CO. LTD. bought a new position in shares of National Health Investors in the fourth quarter worth about $58,000. Jones Financial Companies Lllp boosted its stake in shares of National Health Investors by 781.2% in the 4th quarter. Jones Financial Companies Lllp now owns 890 shares of the real estate investment trust’s stock valued at $62,000 after purchasing an additional 789 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in shares of National Health Investors by 5,000.0% in the 1st quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust’s stock valued at $68,000 after purchasing an additional 900 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Source: marketbeat.com
